The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Sabra Healthcare REIT Inc shares valued at $200,376 were sold by FOSTER MICHAEL J on May 20 ’25. At $18.22 per share, FOSTER MICHAEL J sold 11,000 shares. The insider’s holdings dropped to 64,725 shares worth approximately $1.25 million following the completion of this transaction.
Also, Michael J. Foster purchased 11,000 shares, netting a total of over 192,500 in proceeds.
Before that, Cusack Catherine had added 1,500 shares to its account. In a trade valued at $23,880, the Director bought Sabra Healthcare REIT Inc shares for $15.92 each. Upon closing the transaction, the insider’s holdings increased to 1,500 shares, worth approximately $1.17 million.
As published in a research note from Truist on January 17, 2025, Sabra Healthcare REIT Inc [SBRA] has been rated down from a Buy to a Hold. Analysts at JMP Securities upgraded the stock from ‘”a Mkt perform”‘ to ‘”a Mkt outperform”‘ outlook in a report released in early January. As of December 05, 2024, Mizuho has decreased its “an Outperform” rating to a “Neutral” for SBRA. Earlier on October 01, 2024, Wells Fargo upgraded its rating. Their new recommendation was “an Overweight” for SBRA stock which previously was a “an Equal weight”.
Analyzing SBRA Stock Performance
On last trading session, Sabra Healthcare REIT Inc [NASDAQ: SBRA] plunged -1.53% to $19.31. The stock’s lowest price that day was $19.075, but it reached a high of $19.59 in the same session. During the last five days, there has been a drop of approximately -1.58%. Over the course of the year, Sabra Healthcare REIT Inc shares have jumped approximately 17.04%. Shares of the company reached a 52-week high of $19.97 on 08/22/25 and a 52-week low of $15.60 on 02/21/25.
Support And Resistance Levels for Sabra Healthcare REIT Inc (SBRA)
According to the 24-hour chart, there is a support level at 19.06, which, if violated, would cause prices to drop to 18.81. In the upper region, resistance lies at 19.57. The next price resistance is at 19.84. RSI (Relative Strength Index) is 59.60 on the 14-day chart, showing neutral technical sentiment.
Is Sabra Healthcare REIT Inc subject to short interest?
Stocks of Sabra Healthcare REIT Inc saw a sharp steep in short interest on 2025-08-15 dropping by -2.1 million shares to 18.07 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 20.17 million shares. A decline of -11.63% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 7.03 of the overall float, the days-to-cover ratio (short ratio) decline to 7.03.
Which companies own the most shares of Sabra Healthcare REIT Inc (SBRA)?
In terms of Sabra Healthcare REIT Inc share price expectations, FactSet research, analysts set an average price target of 18 in the next 12 months, down nearly -8.21% from the previous closing price of $19.61. Analysts anticipate Sabra Healthcare REIT Inc stock to reach 20 by 2025, with the lowest price target being 13. In spite of this, 7 analysts ranked Sabra Healthcare REIT Inc stock as Hold at the end of 2025. On September 13, 2024, Citigroup assigned a price target of “a Buy” to the stock and upgraded coverage with a $20.
